В каталог

    Clinical Trials

    253 курсов
    HEALEY ALS Platform Trial: Mechanism of Action and Science Webinar - DNL343, Regimen G
    MassGeneralHospital

    HEALEY ALS Platform Trial: Mechanism of Action and Science Webinar - DNL343, Regimen G

    Global Differences in Heart Failure Etiology, Treatment, and Outcomes
    Cardiology University of Washington

    Global Differences in Heart Failure Etiology, Treatment, and Outcomes

    Genetic Therapies for Severe Neurovascular Disorders - From Bedside to Bench and Back Again
    MassGeneralHospital

    Genetic Therapies for Severe Neurovascular Disorders - From Bedside to Bench and Back Again

    Automating Low-Flow Anesthesia with End-Tidal Control - A Technical Overview
    GE HealthCare

    Automating Low-Flow Anesthesia with End-Tidal Control - A Technical Overview

    Pharmacotherapy for Obesity: An Update - Lecture
    MonteHeart Lectures

    Pharmacotherapy for Obesity: An Update - Lecture

    Non-invasive Imaging of Coronary Artery Disease - Trials, Tribulations and Transformations
    MonteHeart Lectures

    Non-invasive Imaging of Coronary Artery Disease - Trials, Tribulations and Transformations

    Updates from ACC 2024 - Cardiology Rounds
    University of Ottawa Heart Institute

    Updates from ACC 2024 - Cardiology Rounds

    Oral Anticoagulation in 2024: Lessons from Randomized Trials
    University of Ottawa Heart Institute

    Oral Anticoagulation in 2024: Lessons from Randomized Trials

    Implementation of High-Sensitivity Troponin Cardiac Troponin T - The Time is Now
    Minneapolis Heart Institute Foundation

    Implementation of High-Sensitivity Troponin Cardiac Troponin T - The Time is Now

    Classic Biostatistics Videos
    MedNStat Reviews for the Boards

    Classic Biostatistics Videos

    UseR! 2020: Biostatistics
    R Consortium

    UseR! 2020: Biostatistics

    Using Discrepancy Theory to Improve the Design of Randomized Controlled Trials - Daniel Spielman
    Institute for Advanced Study

    Using Discrepancy Theory to Improve the Design of Randomized Controlled Trials - Daniel Spielman

    Antiplatelet Therapy in 2022 - A Practical Review
    University of Ottawa Heart Institute

    Antiplatelet Therapy in 2022 - A Practical Review

    The Challenges of Clinical Trials in Surgery
    University of Ottawa Heart Institute

    The Challenges of Clinical Trials in Surgery

    Hot Topics in Atrial Fibrillation Screening and Subclinical AF
    University of Ottawa Heart Institute

    Hot Topics in Atrial Fibrillation Screening and Subclinical AF

    Revascularization in Ischemic Cardiomyopathy - Cardiology Rounds
    University of Ottawa Heart Institute

    Revascularization in Ischemic Cardiomyopathy - Cardiology Rounds

    Genetic Aortopathy - Updates from 2022 AHA/ACC Guidelines and TITAN Clinical Trials
    University of Ottawa Heart Institute

    Genetic Aortopathy - Updates from 2022 AHA/ACC Guidelines and TITAN Clinical Trials

    Cardiac Amyloidosis: Clinical Cases, Therapies, and Patient Outcomes
    University of Ottawa Heart Institute

    Cardiac Amyloidosis: Clinical Cases, Therapies, and Patient Outcomes

    Defining the Role of Dual Antiplatelet Therapy After Coronary Artery Bypass Surgery
    University of Ottawa Heart Institute

    Defining the Role of Dual Antiplatelet Therapy After Coronary Artery Bypass Surgery

    Targeting Inflammation in Cardiovascular Disease - From Canakinumab to Colchicine
    University of Ottawa Heart Institute

    Targeting Inflammation in Cardiovascular Disease - From Canakinumab to Colchicine

    The Next Horizon of Anticoagulation - Current and Future Research Priorities
    University of Ottawa Heart Institute

    The Next Horizon of Anticoagulation - Current and Future Research Priorities